- $8.70m
- $9.13m
- $0.00m
Annual income statement for Cytta, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.049 | 0.095 | 0.006 | 0.03 | 0.004 |
| Cost of Revenue | |||||
| Gross Profit | 0.024 | 0.053 | 0.006 | — | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 1.31 | 2.67 | 5.06 | 4.65 | 3.89 |
| Operating Profit | -1.27 | -2.57 | -5.05 | -4.62 | -3.89 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.27 | -2.59 | -5.1 | -4.73 | -4.26 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.27 | -2.59 | -5.1 | -4.73 | -4.26 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.27 | -2.59 | -5.1 | -4.73 | -4.26 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.27 | -2.59 | -5.1 | -4.73 | -4.26 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.004 | -0.009 | -0.014 | -0.012 | -0.009 |
| Dividends per Share |